Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study

Use of fibrates is not associated with reduced risks of mortality or cardiovascular events among ESRD patients: A national cohort study

BackgroundAlthough a recent study reported that fibrates are associated with a low risk of cardiovascular (CV) death and can postpone the need for long-term hemodialysis in patients with advanced chronic kidney disease (CKD), little is known regarding whether the CV protective effects of fibrates ex...

Descripció completa

Dades bibliogràfiques
Autors principals:	Wen-Yu Ho, Chieh-Li Yen, Cheng-Chia Lee, Yi-Ran Tu, Chao-Yu Chen, Ching-Chung Hsiao, Pao-Hsien Chu, Hsiang-Hao Hsu, Ya-Chun Tian, Chih-Hsiang Chang
Format:	Article
Idioma:	English
Publicat:	Frontiers Media S.A. 2022-11-01
Col·lecció:	Frontiers in Cardiovascular Medicine
Matèries:	fibrates hypertriglyceridemia end-stage renal disease cardiovascular mortality
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.907539/full

Ítems similars

Fibrate and the risk of cardiovascular disease among moderate chronic kidney disease patients with primary hypertriglyceridemia
per: Chieh-Li Yen, et al.
Publicat: (2024-02-01)

Clifford Fibrations and Possible Kinematics
per: Alan S. McRae
Publicat: (2009-07-01)

Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease
per: Chieh‐Li Yen, et al.
Publicat: (2022-10-01)

Chemical degradation kinetics of fibrates: bezafibrate, ciprofibrate and fenofibrate
per: Marcelo Antonio de Oliveira, et al.

Digital <i>h</i>-Fibrations and Some New Results on Digital Fibrations
per: Talip Can Termen, et al.
Publicat: (2024-03-01)

Lipid management in the prevention of stroke: a meta-analysis of fibrates for stroke prevention
per: Zhou Yu-Hao, et al.
Publicat: (2013-01-01)

Supersymmetry and the Hopf fibration
per: Simon Davis
Publicat: (2012-10-01)

Anti-atherogenic effects of fibrates in type 2 diabetes
per: Barter Philip
Publicat: (2001-09-01)

(Co-)fibration of generalized crossed modules
per: Hatice Gülsün Akay
Publicat: (2024-11-01)

Farmacologia do fibratos Pharmacology of fibrates
per: Hermes Toros Xavier
Publicat: (2005-10-01)

A Fibrational Method of Indexed Coinductive Data Types
per: Decheng Miao, et al.
Publicat: (2020-01-01)

Fibrates for Primary Biliary Cholangitis: What’s All the Hype?
per: Cynthia Levy
Publicat: (2017-09-01)

Risk of Venous Thromboembolism in Statin Users Compared to Fibrate Users in the United Kingdom Clinical Practice Research Datalink (UK CPRD) GOLD
per: Ayodele O, et al.
Publicat: (2024-10-01)

On retracting properties and covering homotopy theorem for S-maps into Sχ-cofibrations and Sχ-fibrations
per: Amin Saif, et al.
Publicat: (2016-10-01)

Associação de medicamentos: estatinas e fibratos Combination of drugs: statins and fibrates
per: Hermes Toros Xavier
Publicat: (2005-10-01)

Codimension 2 fibrators that are closed under finite product
per: Young Ho Im, et al.
Publicat: (1998-01-01)

Inductive Data Types Based on Fibrations Theory in Programming
per: Decheng Miao, et al.
Publicat: (2016-03-01)

Hydrogen sulfide donor-based fibrates: Design, synthesis, and evaluation for hypolipidemic activity and hepatoprotection
per: Wenhua Sun, et al.
Publicat: (2024-06-01)

Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?
per: Tenenbaum Alexander, et al.
Publicat: (2004-12-01)

Exploring the mechanism of fibrates regulating HIF-1A in the treatment of ischemic stroke based on network pharmacology and molecular docking
per: Fengjiao Yang, et al.
Publicat: (2024-12-01)

Ample vector bundles and intrinsic quadric fibrations over irrational curves
per: Tommaso De Fernex
Publicat: (2000-05-01)

Normalization of the levels of inflammatory molecules in Mycobacterium smegmatis-infected U937 cells by fibrate pretreatment
per: Sung-Jo Kim, et al.
Publicat: (2014-01-01)

MIXED SERRE FIBRATION
per: Zahraa Yassin Habeeb, et al.
Publicat: (2022-09-01)

Flavonoids and fibrate modulate apoE4-induced processing of amyloid precursor protein in neuroblastoma cells
per: Viralkumar Davra, et al.
Publicat: (2023-12-01)

Residual Cardiovascular Risk in Diabetic Patients: The Role of Fibrate Statin Combination
per: Angelos Liontos, et al.
Publicat: (2014-10-01)

Elucidating the Effects of the Lipids Regulators Fibrates and Statins on the Health Status of Finfish Species: A Review
per: Manuel Blonç, et al.
Publicat: (2023-02-01)

Design and synthesis of guaiacol-based fibrate derivatives with potential hypolipidemic and liver protective actions
per: Yan Zhang, et al.
Publicat: (2024-01-01)

Stable Higgs bundles over positive principal elliptic fibrations
per: Biswas Indranil, et al.
Publicat: (2018-11-01)

Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study
per: Guilherme Grossi Lopes Cançado, et al.
Publicat: (2022-01-01)

BAR502/fibrate conjugates: synthesis, biological evaluation and metabolic profile
per: Claudia Finamore, et al.
Publicat: (2024-07-01)

Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study
per: Lin Zhu, et al.
Publicat: (2020-03-01)

Impact of concomitant fibrates on immunotherapy outcomes for advanced non‐small cell lung cancer
per: William A. Stokes, et al.
Publicat: (2023-01-01)

A validation study comparing existing prediction models of acute kidney injury in patients with acute heart failure
per: Tao Han Lee, et al.
Publicat: (2021-05-01)

Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies
per: Alessandra Ammazzalorso, et al.
Publicat: (2019-01-01)

Statins and/or fibrates for diabetic retinopathy: a systematic review and meta-analysis
per: Vânia Mozetic, et al.
Publicat: (2019-11-01)

Association of pre-ESRD care education with patient outcomes in a 10-year longitudinal study of patients with CKD stages 3–5 in Taiwan
per: Chu-Lin Chou, et al.
Publicat: (2021-11-01)

Continuation of fibrate therapy in patients with metabolic syndrome and COVID-19: a beneficial regime worth pursuing
per: Alpo Vuorio, et al.
Publicat: (2022-12-01)

Antifungal Activity of Fibrate-Based Compounds and Substituted Pyrroles That Inhibit the Enzyme 3-Hydroxy-methyl-glutaryl-CoA Reductase of Candida glabrata (CgHMGR), Thus Decreasing Yeast Viability and Ergosterol Synthesis
per: Damián A. Madrigal-Aguilar, et al.
Publicat: (2022-04-01)

Risk of Chronic Kidney Disease in Pneumoconiosis: Results from a Retrospective Cohort Study (2008–2019)
per: Chao-Hsuan Wei, et al.
Publicat: (2023-01-01)

Fibrates: A Possible Treatment Option for Patients with Abdominal Aortic Aneurysm?
per: Naofumi Amioka, et al.
Publicat: (2022-01-01)